Industry
Biotechnology
Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. Anew Medical, Inc. is based in Omaha, Nebraska.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
September 17, 2024 | 10:34 am
Portfolio Pulse from Avi Kapoor
September 10, 2024 | 10:41 am
Portfolio Pulse from Benzinga Newsdesk
September 06, 2024 | 4:56 pm
Portfolio Pulse from Benzinga Newsdesk
September 05, 2024 | 4:36 pm
Portfolio Pulse from Benzinga Newsdesk
August 28, 2024 | 6:10 pm
Portfolio Pulse from Benzinga Newsdesk
August 26, 2024 | 9:02 am
Portfolio Pulse from Erica Kollmann
August 21, 2024 | 7:23 pm
Portfolio Pulse from Benzinga Newsdesk
August 21, 2024 | 11:56 am
Portfolio Pulse from Avi Kapoor
August 21, 2024 | 9:47 am
Portfolio Pulse from Benzinga Newsdesk
August 21, 2024 | 9:03 am
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.